Table of Content



Chapter 1 Pharmaceutical Manufacturing Market: Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 List of Secondary Sources
1.9 List of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Pharmaceutical Manufacturing Market: Executive Summary
2.1 Pharmaceutical Manufacturing Market: Market Outlook
2.2 Pharmaceutical Manufacturing Market: Market Segmentation
2.3 Pharmaceutical Manufacturing Market: Competitive Insights
2.4 Market Summary
Chapter 3 Pharmaceutical Manufacturing Market: Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping for Route of Administration, 2019
3.2 Pharmaceutical Manufacturing: Pipeline Analysis
3.3 Pharmaceutical Manufacturing: Medicine Usage and Spending
3.4 Pharmaceutical Manufacturing Market: Impact of COVID-19 Infection
3.4.1 Effects on supply chain
3.4.2 Distribution and logistics concerns
3.4.3 Pharma research into COVID-19
3.5 Pharmaceutical Manufacturing: Regulatory Framework
3.5.1 Regulatory framework in the U.S.
3.5.2 Regulatory framework in the Europe
3.5.3 Regulatory framework in China
3.5.4 Regulatory framework in India
3.5.5 Regulatory framework in Brazil
3.6 Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Rise in pharmaceutical R&D spending
3.6.1.2 Advancements in pharmaceutical manufacturing technologies
3.6.1.3 Rise in focus towards healthcare needs of emerging nations
3.6.1.4 Growth in geriatric population and incidence rate of chronic disorders
3.6.2 Market restraint analysis
3.6.2.1 Patent expiration of most profitable drugs
3.6.2.2 Pricing pressures on pharmaceutical companies
3.6.3 Market challenge analysis
3.6.3.1 Challenges pertaining pharma supply chain
3.6.3.2 Lack of skilled professionals
3.6.4 Market opportunity analysis
3.6.4.1 Increase in number of clinical trials
3.6.4.2 Investment and funding programs in pharmaceutibcal manufacturing industry
3.7 Business environment analysis
3.7.1 Pharmaceutical manufacturing market: SWOT analysis; by factor (political & legal, economic and technological)
3.7.2 Porter’s Five Forces analysis
3.8 Market Strategic Alliances
3.8.1 Agreement
3.8.2 Merger & acquisition
3.8.3 Partnership & collaboration
3.9 Market Entry Strategies
3.9.1 Entry strategies
3.9.2 Market entry strategies for small and midsized companies
Chapter 4 Pharmaceutical Manufacturing Market: Drug Development Type Business Analysis
4.1 Pharmaceutical Manufacturing Market: Drug Development Type Movement Analysis
4.2 In-house
4.2.1 Global in-house pharmaceutical manufacturing market, 2016 - 2027 (USD Billion)
4.3 Outsource
4.3.1 Global Outsource Pharmaceutical Manufacturing Market, 2016 - 2027 (USD Billion)
Chapter 5 Pharmaceutical Manufacturing Market: Formulation Business Analysis
5.1 Pharmaceutical Manufacturing Market: Formulation Movement Analysis
5.2 Tablets
5.2.1 Global pharmaceutical manufacturing market for tablets, 2016 - 2027 (USD Billion)
5.3 Capsules
5.3.1 Global pharmaceutical manufacturing market for capsules, 2016 - 2027 (usd Billion)
5.4 Injectable
5.4.1 Global pharmaceutical manufacturing market for injectable, 2016 - 2027 (USD Billion)
5.5 Sprays
5.5.1 Global pharmaceutical manufacturing market for sprays, 2016 - 2027 (USD Billion)
5.6 Suspensions
5.6.1 Global pharmaceutical manufacturing market for suspensions, 2016 - 2027 (USD Billion)
5.7 Powders
5.7.1 Global pharmaceutical manufacturing market for powders, 2016 - 2027 (USD Billion)
5.8 Other Formulations
5.8.1 Global pharmaceutical manufacturing market for other formulations, 2016 - 2027 (USD Billion)
Chapter 6 Pharmaceutical Manufacturing Market: Routes Of Administration Business Analysis
6.1 Pharmaceutical Manufacturing Market: Routes of Administration Movement Analysis
6.2 Oral
6.2.1 Global pharmaceutical manufacturing market for oral route of administration, 2016 - 2027 (USD Billion)
6.3 Topical
6.3.1 Global pharmaceutical manufacturing market for topical route of administration, 2016 - 2027 (USD Billion)
6.4 Parenteral
6.4.1 Global pharmaceutical manufacturing market for parenteral route of administration, 2016 - 2027 (USD Billion)
6.5 Inhalations
6.5.1 Global pharmaceutical manufacturing market for inhalations route of administration, 2016 - 2027 (USD Billion)
6.6 Other Routes of Administration
6.6.1 Global pharmaceutical manufacturing market for other route of administration, 2016 - 2027 (USD Billion)
Chapter 7 Pharmaceutical Manufacturing Market: Therapy Area Business Analysis
7.1 Pharmaceutical Manufacturing Market: Therapy Area Movement Analysis
7.2 Cardiovascular Diseases
7.2.1 Global pharmaceutical manufacturing market for cardiovascular diseases, 2016 - 2027 (USD Billion)
7.3 Pain
7.3.1 Global pharmaceutical manufacturing market for pain, 2016 - 2027 (USD Billion)
7.4 Diabetes
7.4.1 Global pharmaceutical manufacturing market for diabetes, 2016 - 2027 (USD Billion)
7.5 Cancer
7.5.1 Global pharmaceutical manufacturing market for cancer, 2016 - 2027 (USD Billion)
7.6 Respiratory Diseases
7.6.1 Global pharmaceutical manufacturing market for respiratory diseases, 2016 - 2027 (USD Billion)
7.7 Other Diseases
7.7.1 Global pharmaceutical manufacturing market for other diseases, 2016 - 2027 (USD Billion)
Chapter 8 Pharmaceutical Manufacturing Market: Prescription Business Analysis
8.1 Pharmaceutical Manufacturing Market: Prescription Movement Analysis
8.2 Prescription Medicines
8.2.1 Global pharmaceutical manufacturing market for prescription medicines, 2016 - 2027 (USD Billion)
8.3 Over-the-counter (OTC) Medicines
8.3.1 Global pharmaceutical manufacturing market for OTC medicines, 2016 - 2027 (USD billion)
Chapter 9 Pharmaceutical Manufacturing Market: Age GroupBusiness Analysis
9.1 Pharmaceutical Manufacturing Market: Age GroupMovement Analysis
9.2 Children & Adolescents
9.2.1 Global pharmaceutical manufacturing market for children & adolescents, 2016 - 2027 (USD Billion)
9.3 Adults
9.3.1 Global pharmaceutical manufacturing market for adults, 2016 - 2027 (USD Billion)
9.4 Geriatric
9.4.1 Global pharmaceutical manufacturing market for geriatric, 2016 - 2027 (USD Billion)
Chapter 10 Pharmaceutical Manufacturing Market: Distribution Channel Business Analysis
10.1 Pharmaceutical Manufacturing Market: Distribution Channel Movement Analysis
10.2 Retail
10.2.1 Global pharmaceutical manufacturing market for retail channels, 2016 - 2027 (USD Billion)
10.3 Non-retail
10.3.1 Global pharmaceutical manufacturing market for non-retail, 2016 - 2027 (USD Billion)
Chapter 11 Pharmaceutical Manufacturing Market: Regional Business Analysis
11.1 Pharmaceutical Manufacturing Market: Regional Movement Analysis, 2019 & 2027
11.2 North America
11.2.1 North America pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
11.2.2 The U.S.
11.2.2.1 The U.S. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027(USD Billion)
11.2.2.2 The U.S. pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.2.2.3 The U.S. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.2.2.4 The U.S. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.2.2.5 The U.S. pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.2.2.6 The U.S. pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.2.2.7 The U.S. pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.2.3 Canada
11.2.3.1 Canada pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.2.3.2 Canada pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.2.3.3 Canada pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.2.3.4 Canada pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.2.3.5 Canada pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.2.3.6 Canada pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.2.3.7 Canada pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.3 Europe
11.3.1 Europe pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
11.3.2 Germany
11.3.2.1 Germany pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.3.2.2 Germany pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.3.2.3 Germany pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.3.2.4Germany pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.3.2.5 Germany pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.3.2.6 Germany pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.3.2.7 Germany pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.3.3 The U.K.
11.3.3.1 The U.K. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.3.3.2 The U.K. pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.3.3.3 The U.K. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.3.3.4 The U.K. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.3.3.5 The U.K. pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.3.3.6 The U.K. pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.3.3.7 The U.K. pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.3.4 France
11.3.4.1 France pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.3.4.2 France pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.3.4.3 France pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.3.4.4 France pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.3.4.5 France pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.3.4.6 France pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.3.4.7 France pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.3.5 Italy
11.3.5.1 Italy pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.3.5.2 Italy pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.3.5.3 Italy pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.3.5.4Italy pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.3.5.5 Italy pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.3.5.6 Italy pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.3.5.7 Italy pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.3.6 Spain
11.3.6.1 Spain pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.3.6.2 Spain pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.3.6.3 Spain pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.3.6.4Spain pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.3.6.5 Spain pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.3.6.6 Spain pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.3.6.7 Spain pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.4 Asia-Pacific
11.4.1 Asia Pacific pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
11.4.2 Japan
11.4.2.1 Japan pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.4.2.2 Japan pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.4.2.3 Japan pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.4.2.4Japan pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.4.2.5 Japan pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.4.2.6 Japan pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.4.2.7 Japan pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.4.3 China
11.4.3.1 China pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.4.3.2China pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.4.3.3China pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.4.3.4China pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.4.3.5China pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.4.3.6China pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.4.3.7China pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.4.4 India
11.4.4.1 India pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.4.4.2India pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.4.4.3India pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.4.4.4India pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.4.4.5India pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.4.4.6India pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.4.4.7India pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.5 Latin America
11.5.1 Latin America pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
11.5.2 Brazil
11.5.2.1 Brazil pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.5.2.2Brazil pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.5.2.3Brazil pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.5.2.4Brazil pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.5.2.5Brazil pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.5.2.6Brazil pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.5.2.7Brazil pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.5.3 Mexico
11.5.3.1 Mexico pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.5.3.2 Mexico pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.5.3.3 Mexico pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.5.3.4 Mexico pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.5.3.5 Mexico pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.5.3.6 Mexico pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.5.3.7 Mexico pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.6 Middle East and Africa (MEA)
11.6.1 MEA pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
11.6.2 South Africa
11.6.2.1 South Africa pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.6.2.2South Africa pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.6.2.3South Africa pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.6.2.4South Africa pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.6.2.5South Africa pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.6.2.6South Africa pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.6.2.7South Africa pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 - 2027 (USD Billion)
11.6.3.2Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 - 2027 (USD Billion)
11.6.3.3Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 - 2027 (USD Billion)
11.6.3.4Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 - 2027 (USD Billion)
11.6.3.5Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 - 2027 (USD Billion)
11.6.3.6Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by age group, 2016 - 2027 (USD Billion)
11.6.3.7Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 - 2027 (USD Billion)
Chapter 12 Pharmaceutical Manufacturing Market: Competitive Landscape
12.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
12.2 Recent Developments & Impact Analysis, by Key Market Participants
12.3 Public Companies
12.3.1 Top pharmaceutical companies
12.4 Private Companies
12.4.1 List of key emerging companies
12.5 Strategy Framework
12.6 Market Participation Categorization
12.7 Company Profiles
12.7.1 AstraZeneca
12.7.1.1 Company overview
12.7.1.2 Financial performance
12.7.1.3 Product benchmarking
12.7.1.4 Strategic initiatives
12.7.2 F. Hoffmann-La Roche Ltd.
12.7.2.1 Company overview
12.7.2.2 Financial performance
12.7.2.3 Product benchmarking
12.7.2.4 Strategic initiatives
12.7.3 Merck & Co., Inc.
12.7.3.1 Company overview
12.7.3.2 Financial performance
12.7.3.3 Product benchmarking
12.7.3.4 Strategic initiatives
12.7.4 Pfizer, Inc.
12.7.4.1 Company overview
12.7.4.2 Financial performance
12.7.4.3 Product benchmarking
12.7.4.4 Strategic initiatives
12.7.5 Lonza
12.7.5.1 Company overview
12.7.5.2 Financial performance
12.7.5.3 Product benchmarking
12.7.5.4 Strategic initiatives
12.7.6 Novartis AG
12.7.6.1 Company overview
12.7.6.2 Financial performance
12.7.6.3 Product benchmarking
12.7.6.4 Strategic initiatives
12.7.7 GlaxoSmithKline plc
12.7.7.1 Company overview
12.7.7.2 Financial performance
12.7.7.3 Product benchmarking
12.7.7.4 Strategic initiatives
12.7.8 Eli Lilly And Company
12.7.8.1 Company overview
12.7.8.2 Financial performance
12.7.8.3 Product benchmarking
12.7.8.4 Strategic initiatives
12.7.9 Sanofi
12.7.9.1 Company overview
12.7.9.2 Financial performance
12.7.9.3 Product benchmarking
12.7.9.4 Strategic initiatives
12.7.10 Johnson & Johnson
12.7.10.1 Company overview
12.7.10.2 Financial performance
12.7.10.3 Product benchmarking


List of Tables



TABLE 1 Comparison of drug delivery technologies of ten advanced pharmaceutical technologies (1980-2017)
TABLE 2 Number of active drugs by diseases in 2019
TABLE 3 Therapy wise healthcare spending in developed and pharmerging nations in 2017 (USD Billion)
TABLE 4 Top ten most common prescribed drugs in the U.S.
TABLE 5 List of secondary sources include, but are not limited to:
TABLE 6 Number of pipeline products for top pharmaceutical companies
TABLE 7 Number of pipeline products for top pharmaceutical companies
TABLE 8 Major regulatory agencies globally
TABLE 9 Major Indian regulations for pharmaceuticals
TABLE 10 List of major drug patent expirations in 2019
TABLE 11 Major entry strategies
TABLE 12 Advantages and disadvantages of different routes of administration
TABLE 13 List of top cardiovascular drugs
TABLE 14 Recent pediatric labeling information
TABLE 15 North America pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 16 North America pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 17 North America pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 18 North America pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 19 North America pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 20 North America pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 21 North America pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 22 The U.S. pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 23 The U.S. pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 24 The U.S. pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 25 The U.S. pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 26 The U.S. pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 27 The U.S. pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 28 The U.S. pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 29 Canada pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 30 Canada pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 31 Canada pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 32 Canada pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 33 Canada pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 34 Canada pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 35 Canada pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 36 Europe pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 37 Europe pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 38 Europe pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 39 Europe pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 40 Europe pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 41 Europe pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 42 Europe pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 43 Germany pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 44 Germany pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 45 Germany pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 46 Germany pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 47 Germany pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 48 Germany pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 49 Germany pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 50 The U.K. pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 51 The U.K. pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 52 The U.K. pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 53 The U.K. pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 54 The U.K. pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 55 The U.K. pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 56 The U.K. pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 57 France pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 58 France pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 59 France pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 60 France pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 61 France pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 62 France pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 63 France pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 64 Italy pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 65 Italy pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 66 Italy pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 67 Italy pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 68 Italy pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 69 Italy pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 70 Italy pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 71 Spain pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 72 Spain pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 73 Spain pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 74 Spain pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 75 Spain pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 76 Spain pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 77 Spain pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 78 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 79 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 80 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 81 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 82 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 83 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 84 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 85 Japan pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 86 Japan pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 87 Japan pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 88 Japan pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 89 Japan pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 90 Japan pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 91 Japan pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 92 China pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 93 China pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 94 China pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 95 China pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 96 China pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 97 China pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 98 China pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 99 India pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 100 India pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 101 India pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 102 India pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 103 India pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 104 India pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 105 India pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 106 Latin America pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 107 Latin America pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 108 Latin America pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 109 Latin America pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 110 Latin America pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 111 Latin America pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 112 Latin America pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 113 Brazil pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 114 Brazil pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 115 Brazil pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 116 Brazil pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 117 Brazil pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 118 Brazil pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 119 Brazil pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 120 Mexico pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 121 Mexico pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 122 Mexico pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 123 Mexico pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 124 Mexico pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 125 Mexico pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 126 Mexico pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 127 MEA pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 128 MEA pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 129 MEA pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 130 MEA pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 131 MEA pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 132 MEA pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 133 MEA pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 134 South Africa pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 135 South Africa pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 136 South Africa pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 137 South Africa pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 138 South Africa pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 139 South Africa pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 140 South Africa pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 141 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 142 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 143 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 144 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 145 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 146 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 147 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 148 List of key emerging companies
TABLE 149 List of contract manufacturers